The Revenue Rises
  • Politics
  • Stocks
  • Business
  • Economy
Trending Now
Breakouts, Momentum & Moving Averages: 10 Must-See Stock...
Hedge Market Volatility with These Dividend Aristocrats &...
S&P 500 Bullish Patterns: Are Higher Highs Ahead?
Strategic Chaos or Tactical Goldmine? What QQQ’s Chart...
Why ADX Can Mislead You — And How...
S&P 500 on the Verge of 6,000: What’s...
McDonald’s Snack Wrap is officially making a permanent...
Nationwide coordinated retail crime crackdown results in hundreds...
OpenAI tops 3 million paying business users, launches...
Nuclear Power Trio: OKLO, SMR, and CCJ in...

The Revenue Rises

  • Politics
  • Stocks
  • Business
  • Economy
Stocks

S&P 500 Earnings 2024 Q3: Still Overvalued

by admin January 11, 2025
January 11, 2025
S&P 500 Earnings 2024 Q3: Still Overvalued

S&P 500 earnings are in for 2024 Q3, and here is our valuation analysis.

The following chart shows the normal value range of the S&P 500 Index, indicating where the S&P 500 would have to be in order to have an overvalued P/E of 20 (red line), a fairly valued P/E of 15 (blue line), or an undervalued P/E of 10 (green line). Annotations on the right side of the chart show where the range is projected to be based upon earnings estimates through 2025 Q3.



Historically, price has usually remained below the top of the normal value range (red line); however, since about 1998, it has not been uncommon for price to exceed normal overvalue levels, sometimes by a lot. The market has been mostly overvalued since 1992, and it has not been undervalued since 1984. We could say that this is the “new normal,” except that it isn’t normal by GAAP (Generally Accepted Accounting Principles) standards.

We use GAAP earnings as the basis for our analysis. The table below shows earnings projections through September 2025. Keep in mind that the P/E estimates are calculated based upon the S&P 500 close as of December 31, 2024. They will change daily depending on where the market goes from here. It is notable that the P/E remains outside the normal range.

The following table shows where the bands are projected be, based upon earnings estimates through 2025 Q3.

This DecisionPoint chart keeps track of S&P 500 fundamentals, P/E and yield, and it is updated daily — not that you need to watch it that closely, but it is up-to-date when you need it.

CONCLUSION: The market is still very overvalued and the P/E is still well above the normal range. Earnings have ticked up and are projected to trend higher for the next four quarters. Being overvalued doesn’t require an immediate decline to bring valuation back within the normal range, but high valuation applies negative pressure to the market environment.


Watch the latest episode of DecisionPoint on StockCharts TV’s YouTube channel here!


(c) Copyright 2025 DecisionPoint.com


Technical Analysis is a windsock, not a crystal ball.


Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional. Any opinions expressed herein are solely those of the author, and do not in any way represent the views or opinions of any other person or entity.

DecisionPoint is not a registered investment advisor. Investment and trading decisions are solely your responsibility. DecisionPoint newsletters, blogs or website materials should NOT be interpreted as a recommendation or solicitation to buy or sell any security or to take any specific action.


Helpful DecisionPoint Links:

DecisionPoint Alert Chart List

DecisionPoint Golden Cross/Silver Cross Index Chart List

DecisionPoint Sector Chart List

DecisionPoint Chart Gallery

Trend Models

Price Momentum Oscillator (PMO)

On Balance Volume

Swenlin Trading Oscillators (STO-B and STO-V)

ITBM and ITVM

SCTR Ranking

Bear Market Rules

previous post
Disney says about 157 million global users are streaming content with ads
next post
Meta announces end of its DEI programs. Read the memo.

Related Posts

DexCom Stock Rises From the Ashes: A Breakout...

January 18, 2025

Can the S&P 500 Rally Without Tech?

December 4, 2024

S&P 500 Sectors Play Musical Chairs: How To...

February 9, 2025

What Does This Mean for the S&P 500...

August 21, 2024

Equity Markets Rebound As Discretionary Out-Performs

September 17, 2024

Nasdaq DROPS on Weak AMZN, TSLA & GOOGL...

February 12, 2025

Price Momentum Oscillator (PMO) Internals Still a Problem

November 2, 2024

Gold and Silver Are Crushing the S&P 500!...

February 22, 2025

The Master Sentiment Chart You Need to Follow

October 17, 2024

This Is How I Crush The Benchmark S&P...

February 22, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right Now
    • Hedge Market Volatility with These Dividend Aristocrats & Sector Leaders
    • S&P 500 Bullish Patterns: Are Higher Highs Ahead?
    • Strategic Chaos or Tactical Goldmine? What QQQ’s Chart is Whispering Right Now
    • Why ADX Can Mislead You — And How to Avoid It

    Popular Posts

    • 1

      Polls show some good early signs for Kamala Harris

      July 26, 2024
    • 2

      Solana and Cardano: Solana is waiting for a new impulse

      July 18, 2024
    • 3

      The presidential race shifts — modestly, so far — toward Harris

      August 6, 2024
    • 4

      Donald Trump’s imaginary and frightening world

      September 23, 2024
    • 5

      DP Trading Room: PMO Sort on Earnings Darlings

      July 18, 2024

    Categories

    • Business (675)
    • Economy (975)
    • Politics (873)
    • Stocks (765)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: therevenuerises.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 The Revenue Rises. All Rights Reserved.